JP Patent

JP2550631B2 — ピリダジノン誘導体

Assigned to Nissan Chemical Corp · Expires 1996-11-06 · 30y expired

What this patent protects

Patent listed against Tryvio.

Drugs covered by this patent

Tryvio (APROCITENTAN) · Idorsia

Patent Metadata

Patent number: JP2550631B2
Jurisdiction: JP
Classification: —
Expires: 1996-11-06
Drug substance claim: No
Drug product claim: No
Assignee: Nissan Chemical Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.